GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Other Cash Receipts from Operating Activities

LTR Pharma (ASX:LTP) Other Cash Receipts from Operating Activities : A$0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Other Cash Receipts from Operating Activities?

LTR Pharma's Other Cash Receipts from Operating Activities for the six months ended in Jun. 2023 was A$0.00 Mil.

LTR Pharma's Other Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Jun. 2023 was A$0.00 Mil.

LTR Pharma Other Cash Receipts from Operating Activities Historical Data

The historical data trend for LTR Pharma's Other Cash Receipts from Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Other Cash Receipts from Operating Activities Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23
Other Cash Receipts from Operating Activities
- 0.01 -

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23
Other Cash Receipts from Operating Activities - 0.01 -

LTR Pharma Other Cash Receipts from Operating Activities Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Other Cash Receipts from Operating Activities represents cash flow received from other operating activities in the direct cash flow method.

GuruFocus lists following items in "Cash Receipts from Operating Activities" section for non-financial companies:
Receipts from Customers
Receipts from Government Grants
Other Cash Receipts from Operating Activities

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Jun. 2023 was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Other Cash Receipts from Operating Activities Related Terms

Thank you for viewing the detailed overview of LTR Pharma's Other Cash Receipts from Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

LTR Pharma (ASX:LTP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Other Cash Receipts from Operating Activities
Comparable Companies
Traded in Other Exchanges
N/A
Address
9A/204 Alice Street, Brisbane, QLD, AUS, 4000
Website
https://www.ltrpharma.com
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines